SOPHiA GENETICS S.A.
SOPHNASDAQHealthcareMedical - Healthcare Information Services
Previous close
$8.65
+$0.32 · +3.84%
Pre-market
$8.40
−$0.25 · -2.89%
Aug 24, 7:45 AM ET
SOPH company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Hold
Wait — insufficient conviction to act
Valuation
69
Undervalued
Momentum
79
Gaining
Sentiment
50
Mixed
Risk resilience
54
Elevated Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteSOPHiA GENETICS S.A. operates as a specialized company within the healthcare technology sector. The firm provides the SOPHiA DDM platform, a cloud-native Software-as-a-Service (SaaS) solution engineered to analyze diverse multimodal datasets and various diagnostic inputs, thereby extracting valuable insights. This platform, together with its related offerings and services, is widely adopted by hospitals, laboratories, and biopharmaceutical organizations across the globe. Founded in 2011, SOPHiA GENETICS S.A. is headquartered in Saint-Sulpice, Switzerland.
- Industry
- Medical - Healthcare Information Services
- Sector
- Healthcare
- Headquarters
- CH
- CEO
- Ross Muken
- Listed since
- Jul 23, 2021
- Employees
- 415
Market position
Day range
Current $8.65
52-week range
Current $8.65
- Open
- $8.34
- Previous close
- $8.33
- Volume
- 423.26K
- 1.53× average
- Average volume
- 276.74K
- Average daily volume
- Market cap
- 725.69M USD
- Beta
- 0.92
- Market reference 1
- 50-day average
- $6.1696
- +40.20% above average
- 200-day average
- $5.1746
- +67.16% above average
Financials
Financial snapshot
Latest / TTMValuation & yield
- P/E (TTM)
- -7.52×
- P/B (TTM)
- 7.68×
- P/S (TTM)
- 8.42×
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 66.63%
- Operating margin
- -85.01%
- Net margin
- -93.86%
Financial health
- Debt / equity
- 0.74×
Earnings
- EPS beat rate
- 27%
- 3 beats, 7 misses, 1 met estimate
- Average EPS surprise
- +8.61%
- 11 comparable reports
- Latest EPS result
- -0.26
- Estimate -0.21 · Miss by 23.79%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Analyst price target
Average target
$11.50
32.95% upsideRating distribution
8 ratingsRecent analyst actions
SOPH news
SOPH peers
ETFs holding SOPH
Funds reporting this stock among their holdings, ordered by reported position size.
Fidelity Nasdaq Composite Index ETFONEQ- Market value
- 477.87K
- Weight
- —
- AUM
- 10.35B USD
- Expense ratio
- 0.21%
- Price / 1D
- $103.14+0.41%
Harbor Health Care ETF (MEDI)MEDI- Market value
- 202.14K
- Weight
- 0.46%
- AUM
- 44.61M USD
- Expense ratio
- 0.80%
- Price / 1D
- $34.98+0.69%
Acuitas Small Cap Active ETFAIMS- Market value
- 172.95K
- Weight
- 0.20%
- AUM
- 74.33M USD
- Expense ratio
- 0.75%
- Price / 1D
- $28.3937+0.94%
Continue in GoAI
Research SOPHresearch.disclaimer